The National Institute for Health & Care Excellence (External organisation)

Activity: MembershipMembership of committeeResearch

Description

NICE Clinical Expert on Rapid Technology Review Committee 2017-20: Impact – successful appeal of NICE initial decision not to fund the first-in-class systemic photoprotective drug (Afamelanotide) for a photosensitivity disorder (erythropoietic protoporphyria, EPP)
Period20172020
Held atThe National Institute for Health & Care Excellence, United Kingdom
Degree of RecognitionNational

Research Beacons, Institutes and Platforms

  • Lydia Becker Institute
  • Manchester Institute for Collaborative Research on Ageing